All data are based on the daily closing price as of September 1, 2025
v

Vital KSK Holdings

3151.TSE
8.58 USD
0.05
+0.59%

Overview

Last close
8.58 usd
Market cap
414.86M usd
52 week high
9.70 usd
52 week low
7.07 usd
Target price
N/A usd

Valuation

P/E
8.4105
Forward P/E
N/A
Price/Sales
0.1006
Price/Book Value
0.5812
Enterprise Value
290.64M usd
EV/Revenue
0.0712
EV/EBITDA
2.9354

Key financials

Revenue TTM
4.10B usd
Gross Profit TTM
335.86M usd
EBITDA TTM
61.66M usd
Earnings per Share
1.01 usd
Dividend
0.31 usd
Total assets
2.12B usd
Net debt
-124.07M usd

About

Vital KSK Holdings, Inc. engages in the wholesale and retail sale of pharmaceutical products in Japan. It operates through Pharmaceutical Wholesale Business; Pharmacy Business; Veterinary Drug Wholesale Business; and Other Businesses. The company is involved in the nursing care; agrochemical wholesale; and sale of pharmaceuticals, poisonous or deleterious substances, narcotics, quasi-drugs, vaccines, paints, pigments, dyes, medical equipment, sanitary materials, hygiene goods, nursing care products, and beverages. It also engages in the medical and pharmacy consulting business; general freight vehicle transportation; and insurance agency, real estate management, and parking lot operation. Vital KSK Holdings, Inc. was incorporated in 2009 and is headquartered in Setagaya, Japan.
  • Symbol
    3151.TSE
  • Exchange
    TSE
  • Isin
    JP3778280002
  • Country
    Japan
  • Sector
    Healthcare
  • Industry
    Medical Distribution
  • CEO
    Mr. Taisuke Murai
  • Headquarter
    Setagaya
  • Web site
    https://www.vitalksk.co.jp
Jakota Newsletter

Stay ahead in the JAKOTA stock markets with our roundup of vital insights

Icon scroll to top